Bio-Techne Corp Price Today
Bio-Techne Corp
TECH
Healthcare
$9.42B
💰
Market Cap
33.8
💸
Price to Earnings
$1.8
🎉
EPS
+45
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
9 |
Hold |
3 |
Sell |
0 |
Strong Sell |
0 |
TECH Price Forecast Target
59.5 👉 120.0 +102%
TECH EPS Forecast
1.8 👉 2.4 +34%
Financials
Profit Margin
25 %
Revenue Growth
4.5 %
Dividend
$ 0.32
Held Percent
1.1% - Insiders
95.5% - Institutions
3.4% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $1.1B
-
💰 Blackrock Inc. $1.0B
-
💰 State Street Corporation $381.9M
-
💰 BAMCO Inc. $320.4M
-
💰 Select Equity Group, Inc. $268.8M
Stock Ideas
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
Howard Marks Portfolio
Meet Howard Marks, the co-founder and lead of Oaktree Capital Management, a Los Angeles-based investment firm that manages roughly $78 billion in investment capital. Marks has an impressive background in distressed debt, high yield bonds, and conver…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…📮FAQ
Some Frequently Asked Questions.
The Bio-Techne Corp industry is Biotechnology
The Bio-Techne Corp sector is Healthcare
The Bio-Techne Corp forecasted predicted Price to Earnings PE ratio is 25.3
The Bio-Techne Corp Price to Earnings PE ratio is 33.8
The Market Capitalization of Bio-Techne Corp is $9.42B
There are total of 156592569 float shares with 95.5% held by Institutions and 1.1% held by insiders
The MBio-Techne Corp forecasted Earnings per Share EPS is $2.4
The Bio-Techne Corp Earnings per Share EPS is 1.8
The Bio-Techne Corp company has $770215000 gross profits with 25 profit margins
The Bio-Techne Corp Earnings Growth is 0.207% with 0.227% quarterly earnings growth
The Bio-Techne Corp Revenue is $1136701952 with 0.045 revenue growth
The price target for Bio-Techne Corp stock is $120.0 for the high target and $85.0 for the low target
The consensus analyst recommendations for Bio-Techne Corp is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bio-Techne Corp is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 9
- Hold: 3
- Sell: 0
- Strong Sell: 0
The Beta of Bio-Techne Corp is 1.2
The dividend of Bio-Techne Corp is $0.32
The dividend yield of Bio-Techne Corp is 0.0054%
The biggest institutional and mutual fund holders of Bio-Techne Corp stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- BAMCO Inc.
The Bio-Techne Corp ESG Score is 45, with the following breakdown:
- E: 56.89
- S: 56.41
- G: 48.85